Celldex Therapeutics (CLDX) EBT Margin Growth (5y) (2015 - 2026)
Celldex Therapeutics (CLDX) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.03 Mn |
| Dec 31, 2025 | -9.00 Mn |
| Jun 30, 2025 | -402,431.00 |
| Mar 31, 2025 | -829,833.00 |
| Dec 31, 2024 | -2.78 Mn |
| Sep 30, 2024 | 56,638.00 |
| Jun 30, 2024 | -26,348.00 |
| Mar 31, 2024 | -2.59 Mn |
| Dec 31, 2023 | -892,451.00 |
| Sep 30, 2023 | -197,518.00 |
| Jun 30, 2023 | -1.20 Mn |
| Mar 31, 2023 | -40,094.00 |
| Dec 31, 2022 | -97,881.00 |
| Sep 30, 2022 | -577,648.00 |
| Jun 30, 2022 | -2.13 Mn |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -430,838.00 |
| Sep 30, 2021 | -1.22 Mn |
| Jun 30, 2021 | 191,608.00 |
| Mar 31, 2021 | 24,671.00 |